ArticleChemistry & biodiversity2026
Integrative Network Pharmacology and Glucose Uptake Studies Identify Potential Phytochemicals From Syzygium cumini as Promising Antidiabetic Agents.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus (DM) is a multifaceted metabolic illness with significant detrimental effects during the conventional treatment approach. Therefore, this study aims to explore novel therapeutic targets and potential phytoconstituents using an edge-weighted network pharmacology approach. The bioactive compounds from Syzygium cumini were selected based on the literature evidence. Potential gene targets corresponding to these phytoconstituents were identified using gene-disease association, enrichment calculations, and KEGG pathway mapping analysis. These results reveal that PTPN1 is closely associated with the disease progression of DM. Binding interactions between phytochemicals and the candidate gene (PTPN1) were determined using molecular docking combined with molecular dynamics simulation and MM/PBSA calculations. Notably, chrysanthemin derived from S. cumini exhibited substantial inhibitory action in glucose uptake assays using L6 cell lines, PTP1B inhibition, and enzyme kinetics analyses. These findings suggest that this compound might be a promising candidate for PTPN1 inhibition, warranting further extensive research for its potential therapeutic application in DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.